Scoping Review Will Map How Online Health Searches Affect the “Three Highs”
Patients living with hypertension, diabetes and dyslipidaemia increasingly search the internet before they see a clinician, after a visit, and often instead of a visit. This BMJ Open protocol sets out to examine whether that information-seeking behavior is linked with measurable health outcomes across the cluster commonly described as the “three highs.” The question is clinically relevant because these conditions often coexist, accelerate one another through shared vascular and metabolic injury, and demand long-term self-management that depends heavily on patient understanding.
A scoping review is the right tool for this terrain. The literature is likely to span observational studies, interventional work, survey-based analyses, and studies from multiple regions with different internet access patterns and different standards of chronic disease care. Rather than narrowing the field to a single endpoint, the protocol plans to map the available evidence broadly and describe how online searching relates to blood pressure control, glycaemic outcomes, lipid management, adherence, self-care behavior, and other health-related measures that may emerge across the search. In a population where digital behavior can shape medication use, diet, monitoring habits, and help-seeking, the web is no longer just a source of background information. It is part of the care environment.
The protocol follows the Arksey and O’Malley framework, refined by Levac and colleagues, and will be reported in line with PRISMA-ScR. That matters because scoping reviews can drift into narrative generalization if the search process is not disciplined. Here, the authors have planned a structured approach that includes multiple databases and grey literature, with retrieval and screening supervised by a professional librarian. The methodological intent is clear: capture as much of the relevant evidence base as possible while keeping the process transparent enough for other researchers to reproduce.
One sentence captures the central tension in this topic. More information does not automatically mean better outcomes.
The relationship between online searching and health outcomes is plausibly bidirectional. Patients with poorly controlled disease may be more motivated to look up symptoms, treatments, complications, and lifestyle changes. Better-informed patients may also be more likely to adopt salt restriction, glucose monitoring, statin adherence, or prompt medical review. At the same time, internet content can confuse, overstate risk, promote unproven therapies, or generate anxiety that changes behavior in ways that do not improve control. In chronic cardiometabolic disease, the quality of information may shape self-management as much as the quantity of information.
The protocol’s broad outcome framework is one of its strengths. By assessing a wide range of health outcomes, the review is positioned to capture more than a narrow biomedical endpoint. That is important in the “three highs,” where the consequences of online information seeking may show up in medication adherence, clinic attendance, self-monitoring, perceived disease burden, dietary behavior, and clinical markers that are often separated across disciplines. A patient who learns to track home blood pressure readings after searching online may benefit from better recognition of uncontrolled hypertension. Another patient may encounter misleading advice and delay treatment intensification. Both patterns are clinically meaningful, even if they do not fit neatly into a single endpoint hierarchy.
Evidence Mapping Will Span Diverse Designs and Regions
The inclusion strategy is intentionally broad, and with good reason. Digital health behavior is shaped by age, education, language, internet access, health literacy, and regional differences in care delivery. Studies from urban tertiary systems may look very different from community-based research in lower-resource settings. Diverse study designs will broaden the map, but they will also introduce heterogeneity that complicates comparison across findings.
That heterogeneity is not a flaw in the protocol; it is part of the question itself. Online information seeking is not a uniform exposure. A newly diagnosed patient reading a government guideline differs from a long-term patient following social media advice, and both differ again from someone using symptom search engines to interpret warning signs. The review will need to sort these behaviors carefully if it is to distinguish useful engagement from harmful confusion. A search for “what is hypertension” is not equivalent to repeated consultation of algorithm-driven content that encourages self-medication.
Because the review will not include a formal methodological quality assessment, interpretation of the evidence will need to stay anchored to study design and context rather than to a pooled quality score. In a scoping framework, that is expected. The tradeoff is familiar: broader capture in exchange for less certainty about the strength of each included study. For clinicians, that means the final map may show where the evidence cluster is dense, where it is thin, and where contradictory findings are most likely to reflect design limitations rather than true biological disagreement.
Why Digital Behavior Matters in Hypertension, Diabetes and Dyslipidaemia
These three chronic conditions share a vascular endpoint even when they begin along different metabolic pathways. Persistently elevated blood pressure injures the arterial wall, hyperglycaemia drives endothelial dysfunction and microvascular damage, and lipid abnormalities accelerate atherosclerotic plaque formation. Patient behavior influences each pathway. If online information helps someone adhere to antihypertensives, monitor glucose, or sustain statin use, the downstream effect can be real. If it distracts them with false reassurance or untested alternatives, the impact can be equally real and far less favorable.
The protocol’s focus on health outcomes rather than only knowledge gain is clinically important. Education is not the same as outcome change. A patient can leave a website more informed yet no better controlled, or more anxious and less adherent. Measuring the relationship between online information seeking and actual health status pushes the review beyond digital literacy into the realm of clinical consequence. That is where the practical question lives for frontline care: does the way patients use the internet help stabilize chronic disease, or does it create a new layer of risk?
A second one-sentence reality check is unavoidable. Digital search behavior can help a patient act sooner, or it can delay care long enough to matter.
What the Review Can and Cannot Deliver
The review is built to chart the field, not to settle it with a single number. It will likely identify which outcomes have been studied most often, which populations have been included, and which forms of online information seeking have been linked to better or worse results. It may also expose blind spots, especially if certain regions, age groups, or internet platforms have been underrepresented in the literature.
What it will not do is assign a definitive causal label to the relationship between internet use and disease control. That is a structural limitation of the scoping design, reinforced by the decision not to perform formal quality appraisal. Still, the protocol is clinically valuable because it treats online information seeking as a serious determinant of chronic disease management rather than as a peripheral social habit. In hypertension, diabetes, and dyslipidaemia, patient behavior is part of the treatment pathway. The internet now sits inside that pathway, and this review is designed to show exactly where the evidence supports that reality and where the field still lacks enough data to judge the direction of effect.